268 related articles for article (PubMed ID: 25663695)
1. Conceptualizing overdiagnosis in cancer screening.
Marcus PM; Prorok PC; Miller AB; DeVoto EJ; Kramer BS
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663695
[TBL] [Abstract][Full Text] [Related]
2. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
3. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening gets risk-specific.
Peres J
J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
[No Abstract] [Full Text] [Related]
5. Cancer overdiagnosis and overtreatment.
Klotz L
Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
[TBL] [Abstract][Full Text] [Related]
6. PSA measurement and prostate cancer--overdiagnosis and overtreatment?
Breidablik HJ; Meland E; Aakre KM; Førde OH
Tidsskr Nor Laegeforen; 2013 Sep; 133(16):1711-6. PubMed ID: 24005707
[TBL] [Abstract][Full Text] [Related]
7. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
8. Screening for prostate cancer: an updated review.
Marta GN; Hanna SA; Fernandes da Silva JL; Carvalho Hde A
Expert Rev Anticancer Ther; 2013 Jan; 13(1):101-8. PubMed ID: 23259431
[TBL] [Abstract][Full Text] [Related]
9. Solving the overdiagnosis dilemma.
Esserman L; Thompson I
J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
[No Abstract] [Full Text] [Related]
10. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
11. Overdiagnosis in cancer.
Welch HG; Black WC
J Natl Cancer Inst; 2010 May; 102(9):605-13. PubMed ID: 20413742
[TBL] [Abstract][Full Text] [Related]
12. Cancer screening rates in individuals with different life expectancies.
Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
[TBL] [Abstract][Full Text] [Related]
13. Cancer, concepts, cohorts and complexity: avoiding oversimplification of overdiagnosis.
Detterbeck FC
Thorax; 2012 Sep; 67(9):842-5. PubMed ID: 22628119
[No Abstract] [Full Text] [Related]
14. [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].
Bratt O; Lundgren R; Ahlgren G
Lakartidningen; 2012 Sep 12-18; 109(37):1610-2. PubMed ID: 23077769
[No Abstract] [Full Text] [Related]
15. [Overdiagnosis in cancer].
Marzo-Castillejo M; Vela-Vallespín C
Aten Primaria; 2018 Nov; 50 Suppl 2(Suppl 2):51-56. PubMed ID: 30268494
[TBL] [Abstract][Full Text] [Related]
16. How to prevent overdiagnosis.
Chiolero A; Paccaud F; Aujesky D; Santschi V; Rodondi N
Swiss Med Wkly; 2015; 145():w14060. PubMed ID: 25612105
[TBL] [Abstract][Full Text] [Related]
17. [Mass screening for detection of prostatic carcinoma].
Bangma CH
Urologe A; 2000 Jul; 39(4):334-40. PubMed ID: 10957775
[TBL] [Abstract][Full Text] [Related]
18. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
[TBL] [Abstract][Full Text] [Related]
19. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
[TBL] [Abstract][Full Text] [Related]
20. Overdiagnosis in early detection programs.
Davidov O; Zelen M
Biostatistics; 2004 Oct; 5(4):603-13. PubMed ID: 15475422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
